Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02651662
Title Study of REGN2810 and REGN1979 in Patients With Lymphoma
Acronym CLIO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ISR | ESP | DEU

Facility Status City State Zip Country Details
Regeneron Research Facility WITHDRAWN Baltimore Maryland 21287 United States Details
Regeneron Research Facility RECRUITING Boston Massachusetts 02215 United States Details
Regeneron Research Facility WITHDRAWN Heidelberg Baden-Wurttemberg 69120 Germany Details
Hadassah Medical Center RECRUITING Jerusalem 91200 Israel Details
Chaim Sheba Medical Center RECRUITING Ramat-Gan 5265601 Israel Details
Tel Aviv Sourasky Medical Center RECRUITING Tel Aviv 64239 Israel Details
Pratia MCM Kraków RECRUITING Krakow Malopolska 02781 Poland Details
Pratia Onkologia Katowice RECRUITING Katowice 40-519 Poland Details
Regeneron Research Facility RECRUITING Barcelona 08035 Spain Details
Regeneron Research Facility RECRUITING Barcelona 08036 Spain Details
Regeneron Research Facility RECRUITING Barcelona 08041 Spain Details
Institut Català d'Oncologia (ICO Hospitalet) RECRUITING Barcelona 08908 Spain Details
Regeneron Research Facility WITHDRAWN Madrid 28033 Spain Details
Regeneron Research Facility RECRUITING Madrid 28040 Spain Details
Regeneron Research Facility RECRUITING Madrid 28041 Spain Details
Regeneron Research Facility RECRUITING Majadahonda 28222 Spain Details
Regeneron Research Facility RECRUITING Salamanca 37007 Spain Details
Regeneron Research Facility RECRUITING Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field